Results 71 to 80 of about 21,386 (303)
Surgical treatment of unicentric plasma cell histological type Castleman's disease [PDF]
, 2011 Introduction. Castleman’s disease or angiofollicular lymph hyperplasia is a rare disease with two identified clinical forms. Unicentric or localized form is characterized by isolated growth of lymph nodes, most often in mediastinum, and multicentric ...
Cvijanović Vlado +6 more
core +1 more source
Castleman disease: an uncommon diagnosis in pediatrics
Autopsy and Case Reports, 2012 First described by Dr. Benjamin Castleman in 1956, Castleman disease is an uncommon disease of an etiology that is not yet thoroughly known. Three distinct histological subtypes have already been described: hyaline-vascular-, plasma cell-, and human ...
Paula Martinez Vianna +6 more
doaj +1 more source
Pediatric multicentric Castleman disease; a case report [PDF]
Journal of Clinical and Investigative Surgery, 2022 Castleman disease (CD) is a rare B-cell lymphoproliferative disorder of unknown etiology characterized by benign lymphoid follicular hyperplasia and capillary proliferation.
Gabriela Alfier +4 more
doaj +1 more source
18F-FDG PET/CT imaging features of patients with multicentric Castleman disease
Nuclear medicine communications, 2021 Objective The aim of this study is to investigate the role of 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in the evaluation of multicentric Castleman disease (MCD).
Yuanyuan Jiang +5 more
semanticscholar +1 more source
Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]
, 2020 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core +1 more source
JCI Insight, 2020 The TAFRO clinical subtype of idiopathic multicentric Castleman disease (iMCD-TAFRO) is a rare hematologic illness involving episodic disease flares of thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly (TAFRO)
R. Pai +14 more
semanticscholar +1 more source
Internal medicine, 2021 This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal rigidity, impaired consciousness, pyramidal tract signs and ...
A. Arakawa +7 more
semanticscholar +1 more source
Multicentric Castleman's disease: a case report [PDF]
Journal of Medical Case Reports, 2007 Castleman's disease is a clinicopathological entity associated with lymphoproliferation. We report a case of a 71 year old gentleman who was initially clinically suspected to have lymphoma (owing to clinical features at presentation), but was later histologically confirmed to have Castleman's disease.
Menezes Brian F +2 more
openaire +3 more sources
Localized Plaques on the Scalp as Initial Presentation of Multicentric Plasmacytic Castleman Disease
Clinical, Cosmetic and Investigational Dermatology, 2022 Heng Zhang, Kun Li, Jianzhong Zhang, Xue Chen Department of Dermatology, Peking University People’s Hospital, Beijing, People’s Republic of ChinaCorrespondence: Xue Chen, Department of Dermatology, Peking University People’s Hospital, # 11.
Zhang H, Li K, Zhang J, Chen X
doaj
Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease
Case Reports in Hematology, 2021 Castleman disease is a rare lymphoproliferative disorder presenting with localized or disseminated lymphadenopathy and systemic symptoms. It can be categorized clinically as unicentric or multicentric, histopathologically as hyaline vascular, plasma cell,
Adelaide Moutinho +4 more
doaj +1 more source